Vaccine Production Program Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Gaithersburg, MD, United States.
Vaccine Production Program Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Gaithersburg, MD, United States.
Vaccine. 2020 Jun 15;38(29):4507-4511. doi: 10.1016/j.vaccine.2020.04.080. Epub 2020 May 22.
An N-terminal peptide of the HIV-1 fusion peptide (FP) with eight amino acid residues (FP8) was conjugated to a recombinant Tetanus Toxoid Heavy Chain Fragment C (rTTHc) as a carrier protein to help boosting immunogenicity against HIV-1. In this rapid communication, a unique algorithm to determine FP-rTTHc conjugation ratio was developed based off the amino acid analysis. Five well recovered amino acids (present in both FP and rTTHc) were used to calculate the conjugation ratio, while proline (present only in rTTHc) was identified and utilized as the intrinsic internal standard for normalization. With this calculation, the assay variability was minimized (<20%), especially for conjugates with moderate to low conjugation ratios as being compared to previously reported methods. The approach offers a reliable tool to determine the efficiency of the conjugation reactions for in-process monitoring and for final conjugate product characterization.
HIV-1 融合肽(FP)的 N 端八肽(FP8)与重组破伤风类毒素重链片段 C(rTTHc)连接作为载体蛋白,以帮助提高针对 HIV-1 的免疫原性。在本快速通讯中,根据氨基酸分析开发了一种确定 FP-rTTHc 连接比的独特算法。使用了五个回收率良好的氨基酸(存在于 FP 和 rTTHc 中)来计算连接比,而脯氨酸(仅存在于 rTTHc 中)被鉴定并用作归一化的固有内标。通过这种计算,最大限度地减少了测定变异性(<20%),特别是与以前报道的方法相比,对于中等至低连接比的缀合物。该方法为过程监测和最终缀合物产品特性提供了一种可靠的工具,用于确定缀合反应的效率。